Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-23,000
Closed -$1.4M 7363
2017
Q1
$1.4M Buy
+23,000
New +$1.38M ﹤0.01% 2849
2016
Q4
Sell
-10,500
Closed -$607K 7203
2016
Q3
$607K Buy
+10,500
New +$618K ﹤0.01% 3719
2014
Q1
Sell
-400
Closed -$16K 7049
2013
Q4
$16K Sell
400
-4,000
-91% -$157K ﹤0.01% 6244
2013
Q3
$161K Buy
4,400
+2,400
+120% +$90.7K ﹤0.01% 4345
2013
Q2
$74K Buy
+2,000
New +$71.4K ﹤0.01% 5093

Other funds holding DOX

Citigroup's DOX Position: Q1 2026 in Review

Citigroup reduced its Amdocs (DOX) stake by 19% in Q1 2026, selling an estimated $1.46M and leaving 86,732 shares worth $5.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Citigroup first reported a position in DOX in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.4M in Q4 2019. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

  • Citigroup held 86,732 shares of Amdocs worth $5.66M as of Q1 2026.
  • Citigroup sold 19,916 Amdocs shares in Q1 2026, an estimated $1.46M.
  • Amdocs made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1865 holding.
  • Citigroup first reported a position in Amdocs in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Amdocs position peaked at $37.4M in Q4 2019.
  • 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.